Gen Two Real Estate Secures Another Life Sciences Property in Cambridge
Gen Two Real Estate has recently agreed to buy a 10,800 sq ft laboratory space in Whittlesford, Cambridge. This deal, expected to be completed later in the year, marks the company’s third investment in the South Cambridge bio-tech area and its second in Whittlesford.
The property, 1 Lion Works, is leased to Alchemab Therapeutics, a company that researches antibody responses for drug development. Alchemab acquired this lease from Avacta Therapeutics in 2022 and has since renovated the building for its specific needs in collaboration with COEL, a specialist fit-out contractor.
The renovations focused on making the space more suitable for their work and improving its sustainability features.
Daniel Sterling, co-founder of Gen Two Real Estate, stated that this acquisition is a step towards growing their collection of life science assets in Cambridgeshire, particularly in the South Cambridge science cluster and at Lion Works, where they already own another property, Recodery building.
Alchemab’s Senior Vice President of Operations & Chief of Staff, Alexander Hewitson, expressed enthusiasm about working with Gen Two and advancing sustainability initiatives together.
The property’s location is a key feature, being situated next to Whittlesford Parkway train station, offering easy access to Cambridge and London.
© Eastern Echo (powered by ukpropertyforums.com).
Sign up to receive our weekly free journal, The Forum here.
